IPP Bureau
Sai Life Sciences is now a United Nations Global Compact (UNGC) signatory
By IPP Bureau - August 26, 2021
In the last two years, Sai Life Sciences has made significant investments and progress in advancing its sustainability agenda as part of its organizational transformation initiative
RedHill Biopharma's Opaganib demonstrates strong inhibition of COVID-19 Delta variant
By IPP Bureau - August 26, 2021
Opaganib, a leading novel small molecule investigational oral pill in development for Covid-19, is a unique host targeted, dual antiviral and anti-inflammatory drug that acts on the cause and effect of the disease
Strong show in domestic formulations business by Indian pharma in Q1FY22: Ind-Ra
By IPP Bureau - August 26, 2021
Domestic business was up 41.9% YoY and 27.7% QoQ
Pune-based Jehangir Hospital records 500 kidney transplants
By IPP Bureau - August 25, 2021
The hospital works in close collaboration with the Network for Organ Sharing and the National Organ & Tissue Transplant Organisation (NOTTO) and it is amongst the very few hospitals doing ABO-incompatible transplant
US FDA approves Medtronic’s TAVR System
By IPP Bureau - August 25, 2021
The Evolut FX TAVR system is used for treatment of symptomatic severe aortic stenosis and it has features that enhance ease-of-use and predictable valve deployment
Regimen launches world’s first personalised digital therapy for ED
By IPP Bureau - August 25, 2021
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
Lonza to establish manufacturing facility in Guangzhou, China
By IPP Bureau - August 25, 2021
The investment will establish drug product manufacturing capacity for clinical trial and commercial supply in China and offer customers combined drug substance and drug product manufacturing services
Medtronic partners with ASAP, Kerala for Internship
By IPP Bureau - August 25, 2021
Goal of providing 12-month internship opportunities for qualified students
Cipla forms JV with Kemwell Biopharma
By IPP Bureau - August 25, 2021
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
CRISIL positive on Krishna Institute of Medical Sciences
By IPP Bureau - August 25, 2021
CRISIL Ratings has revised its outlook on the long term ratings of Krishna Institute Of Medical Sciences Limited (KIMS) to 'Positive' from 'Stable' while reaffirming the ratings at 'CRISIL AA-/CRISIL A1+'
Carbogen Amcis AG signs co-investment agreement
By IPP Bureau - August 25, 2021
The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound
Govt to offer incentives to support 75 start-ups in Tele-Medicine, AI and Digital Health
By IPP Bureau - August 25, 2021
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
Pfizer to acquire Trillium Therapeutics
By IPP Bureau - August 24, 2021
Trillium’s portfolio includes biologics that are designed to enhance the ability of patients’ innate immune system to detect and destroy cancer cells
Infosys Foundation constructs OPD block at the Kidwai Memorial Institute of Oncology, Bangalore
By IPP Bureau - August 24, 2021
The foundation has been working closely with the Kidwai Memorial Institute of Oncology on several projects since 2001
New data demonstrates efficacy of Viraleze anti-nasal spray for Covid-19
By IPP Bureau - August 24, 2021
Viraleze was developed for application in the nasal cavity to help reduce exposure to respiratory viruses, including SARS-CoV-2. The product is registered for sale in Europe and India, and available online in certain markets
